Legence Corp. (LGN)
NASDAQ: LGN · Real-Time Price · USD
84.30
-4.70 (-5.28%)
May 15, 2026, 4:00 PM EDT - Market closed

Legence Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Cash & Equivalents
244.62230.1781.1788.92
Cash & Short-Term Investments
244.62230.1781.1788.92
Cash Growth
174.47%183.57%-8.72%-
Accounts Receivable
827.26584.06448.61422.69
Other Receivables
355.75259.94188.13125.37
Total Trade Receivables
1,183844636.74548.07
Other Current Assets
42.9736.1838.5151.68
Total Current Assets
1,4711,110756.42688.67
Net Property, Plant & Equipment
259.16209.47164.3138.02
Other Intangible Assets
843.27551.42624.25618.15
Goodwill
841.96764.34781.19676.03
Other Long-Term Assets
68.1343.8226.345.27
Total Assets
3,4832,6792,3532,126
Accounts Payable
350.32246.16126.5107.39
Accrued Expenses
194.1184.5483.09142.14
Current Portion of Long-Term Debt
18.316.6922.9815.61
Current Portion of Leases
27.421.314.49.83
Unearned Revenue
543.28339.46164.13164.6
Total Current Liabilities
1,133708.16411.11439.56
Long-Term Debt
1,009812.41,5861,035
Long-Term Leases
123.25103.7680.6757.98
Other Long-Term Liabilities
266.64266.2971.2870.33
Total Long-Term Liabilities
1,3991,1821,7381,164
Total Liabilities
2,5321,8912,1491,603
Common Stock
1.081.05--
Additional Paid-in Capital
797701.79--
Accumulated Other Comprehensive Income
1.22-0.79.1122.17
Retained Earnings
-293.86-309.95193.57500.76
Total Common Shareholders' Equity
505.44392.2202.68522.93
Minority Interest
445.6396.60.91-
Shareholders' Equity
951.04788.8203.59522.93
Total Liabilities & Equity
3,4832,6792,3532,126
Total Debt
1,178954.151,7041,119
Net Cash (Debt)
-933.1-723.99-1,623-1,030
Net Cash Per Share
-11.36-12.19-15.94-
Book Value
505.44392.2202.68522.93
Book Value Per Share
6.156.601.99-
Tangible Book Value
-1,180-923.56-1,203-771.25
Tangible Book Value Per Share
-14.37-15.55-11.81-
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q